Khoso Baluch's most recent trade in Processa Pharmaceuticals Inc was a trade of 300,000 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on Oct. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Processa Pharma Inc | Khoso Baluch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 300,000 | 300,000 | - | - | Stock Options (Right to Buy) | |
| Processa Pharma Inc | Khoso Baluch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 100,000 | 100,000 | - | - | Restricted Stock Units | |
| Longeveron Inc (Class A) | Khoso Baluch | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Aug 2025 | 29,415 | 29,415 | - | - | Warrant (right to buy) | |
| Longeveron Inc (Class A) | Khoso Baluch | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Aug 2025 | 11,766 | 52,516 | - | - | Class A Common Stock | |
| Processa Pharma Inc | Khoso Baluch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2025 | 175,299 | 206,505 | - | - | Restricted Stock | |
| Processa Pharma Inc | Khoso Baluch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2025 | 31,206 | 36,275 | - | - | Restricted Stock | |
| Longeveron Inc (Class A) | Khoso Baluch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2025 | 17,000 | 40,750 | - | 0 | Class A Common Stock | |
| Longeveron Inc (Class A) | Khoso Baluch | Director | Sale of securities on an exchange or to another person at price $ 2.07 per share. | 02 Dec 2024 | 1,250 | 23,750 | - | 2.1 | 2,588 | Class A Common Stock |
| Processa Pharma Inc | Khoso Baluch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 31,206 | 31,206 | - | - | Restricted Stock | |
| Longeveron Inc (Class A) | Khoso Baluch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 23,500 | 38,375 | - | 0 | Class A Common Stock | |
| Longeveron Inc (Class A) | Khoso Baluch | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.06 per share. | 09 Jun 2024 | 125 | 14,875 | - | 1.1 | 133 | Common Stock |
| Longeveron Inc (Class A) | Khoso Baluch | Director | Purchase of securities on an exchange or from another person at price $ 1.43 per share. | 28 Dec 2023 | 8,322 | 15,000 | - | 1.4 | 11,915 | Common Stock |
| Longeveron Inc (Class A) | Khoso Baluch | Director | Purchase of securities on an exchange or from another person at price $ 1.40 per share. | 28 Dec 2023 | 1,678 | 6,678 | - | 1.4 | 2,342 | Common Stock |
| Longeveron Inc (Class A) | Khoso Baluch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 12,000 | 12,000 | - | - | Stock Option (Right to buy) | |
| Processa Pharma Inc | Khoso Baluch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 101,365 | 101,365 | - | - | Restricted Stock | |
| Processa Pharma Inc | Khoso Baluch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2023 | 15,455 | 0 | - | - | Restricted Stock | |
| Processa Pharma Inc | Khoso Baluch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2023 | 15,455 | 27,955 | - | - | Common Stock | |
| Longeveron Inc (Class A) | Khoso Baluch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 5,000 | 5,000 | - | 0 | Common Stock | |
| Processa Pharma Inc | Khoso Baluch | Director | Grant, award, or other acquisition of securities at price $ 0.80 per share. | 09 Feb 2023 | 12,500 | 12,500 | - | 0.8 | 10,000 | Common Stock |
| Processa Pharma Inc | Khoso Baluch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2022 | 19,091 | 19,091 | - | - | Restricted Stock | |
| CorMedix Inc | Khoso Baluch | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 320,000 | 320,000 | - | - | Stock Option (Right to Buy Common Stock) |